COMMUNIQUÉS West-GlobeNewswire

EssilorLuxottica: Mise à disposition du Document d’enregistrement universel 2024

10/03/2025 - 18:00

Mise à disposition du Document d’enregistrement universel 2024 Paris, France (10 mars 2025) - EssilorLuxottica annonce la mise à disposition de son Document d’enregistrement universel 2024 dans les conditions requises [...]

EssilorLuxottica: 2024 Universal Registration Document filed

10/03/2025 - 18:00

2024 Universal Registration Document filed Paris, France (10 March 2025) – EssilorLuxottica announces the availability of its 2024 Universal Registration Document, in accordance with applicable regulation. The French [...]

Mental Health and the COVID Vaccine Discussed in the Journal of American Physicians and Surgeons

10/03/2025 - 19:10

TUCSON, Ariz., March 10, 2025 (GLOBE NEWSWIRE) -- In the wake of the COVID pandemic, many persons suffered severe mental health problems, which could have resulted from many causes, writes Jane Orient, M.D. , in the [...]

Long-term Brain Effects from COVID Vaccine Discussed in the Journal of American Physicians and Surgeons

10/03/2025 - 19:23

TUCSON, Ariz., March 10, 2025 (GLOBE NEWSWIRE) -- Rushed into production, the mRNA COVID vaccine was administered to 100 million people too soon to see any possible long-term neurologic effects, particularly in babies [...]

Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025

10/03/2025 - 20:00

Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025 IMC-M113V was well tolerated, with no dose-limiting toxicities Signals of dose-dependent [...]

ACTG Presents Four Studies at CROI Describing Findings from SLIM LIVER

10/03/2025 - 20:00

Presentations highlight relationship between semaglutide and blood markers of gene modification age predictors, gut bacteria, heart and metabolic effects, and fat in the liver LOS ANGELES, March 10, 2025 (GLOBE NEWSWIRE [...]

Defenses against Sham Peer Review Discussed in the Journal of American Physicians and Surgeons

10/03/2025 - 20:08

TUSCON, Ariz. , March 10, 2025 (GLOBE NEWSWIRE) -- False accusations of being a “disruptive physician” can ruin a physician’s career as well as cause moral injury that damages the very core of a physician’s identity, [...]

There Is Hope for American Medicine, Writes President of the Association of American Physicians and Surgeons (AAPS)

10/03/2025 - 20:13

TUSCON, Ariz., March 10, 2025 (GLOBE NEWSWIRE) -- Hope, a very small word with a very large impact, is powerful. Without hope, all is futility, writes Erika L. LeBaron, D.O., M.S.N ., in the spring issue of the Journal [...]

Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences

10/03/2025 - 21:00

NEWTON, Mass., March 10, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers [...]

Mineralys Therapeutics Announces Proposed Public Offering of Common Stock

10/03/2025 - 21:01

RADNOR, Pa., March 10, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD [...]

Tenaya Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

10/03/2025 - 21:05

Dosing Initiated in Cohort 2 of the MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 for Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy MyPEAK-1 Cohort 1 Data Accepted for Late-Breaker Presentation at the [...]

CervoMed Announces Positive Results from the Extension Phase of its Phase 2b Clinical Study of Neflamapimod in Patients with Dementia with Lewy Bodies

10/03/2025 - 21:05

A new batch of neflamapimod capsules led to increased plasma drug concentrations and demonstrated improvement (p<0.001 vs. old capsules; p=0.003 vs. placebo) on the primary outcome measure, change from baseline in [...]

The Ensign Group to Present at the 35th Annual Oppenheimer Healthcare MedTech & Services Conference on March 18, 2025

10/03/2025 - 21:05

SAN JUAN CAPISTRANO, Calif., March 10, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living [...]

OnKure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

10/03/2025 - 21:05

— PIKture-01 trial update including additional PK data, mature single agent and initial combination data expected in the second half of 2025; reported encouraging preliminary data in December 2024 — Expansion of PI3K a [...]

Coherus BioSciences Reports Fourth Quarter, Full Year 2024 Financial Results and Provides Business Update

10/03/2025 - 21:12

– Annual net revenue increased 4% to $267.0 million in 2024, despite significant divestitures – – UDENYCA ® net revenue increased 62% year-over-year – – LOQTORZI ® net revenue increased 29% quarter-over-quarter – – [...]

Crinetics Pharmaceuticals Announces March 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10/03/2025 - 21:36

SAN DIEGO, March 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on March 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock [...]

Viemed Healthcare Announces Record 2024 Financial Results

10/03/2025 - 22:00

LAFAYETTE, La., March 10, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, [...]

Nyxoah Publiera ses Résultats Financiers du Quatrième Trimestre et de l’Exercice 2024 le 13 Mars 2025

10/03/2025 - 22:05

Nyxoah Publiera ses Résultats Financiers du Quatrième Trimestre et de l’Exercice 2024 le 13 Mars 2025 Mont-Saint-Guibert, Belgique – 10 mars 2025, 22h05 CET / 17h05 ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (« [...]

Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025

10/03/2025 - 22:05

Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025 Mont-Saint-Guibert, Belgium – Monday, March 10, 2025, 10:05pm CET / 5:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“ [...]